⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15265769 | 1.00 | USP2 (0.46) | — | |
| SCHEMBL3167 | 1.00 | — | — | |
| SCHEMBL28231022 | 1.00 | USP2 (0.46) | — | |
| SCHEMBL8135220 | 1.00 | — | — | |
| SCHEMBL474212 | 1.00 | — | — | |
| Fluoride SCHEMBL11426086 | 1.00 | USP2 (0.46) | — | |
| SCHEMBL23481366 | 0.97 | ALDH1A1 (0.48) | — | |
| SCHEMBL463266 | 0.97 | ALDH1A1 (0.48) | — | |
| Iodide SCHEMBL10383439 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL996361 | 0.97 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0967965-A4 | LOW FOAMING THERAPEUTIC TOOTHPASTES WITH IMPROVED CLEANING AND ABRASION PERFORMANCE | WHITEHILL ORAL TECH INC (US) | 2001-01-24 | — | — | EP | disclosed |
| EP-0967965-A1 | LOW FOAMING THERAPEUTIC TOOTHPASTES WITH IMPROVED CLEANING AND ABRASION PERFORMANCE | WHITEHILL ORAL TECHNOLOGIES INC. (US) | 2000-01-05 | — | — | EP | disclosed |
| WO-1998004234-A1 | LOW FOAMING THERAPEUTIC TOOTHPASTES WITH IMPROVED CLEANING AND ABRASION PERFORMANCE | WHITEHILL ORAL TECHNOLOGIES, INC. (US) | 1998-02-05 | — | — | WO | disclosed |
| EP-0297213-B1 | ORAL TREATMENT AND USE OF AN ORAL COMPOSITION | THE PROCTER & GAMBLE COMPANY (US) | 1991-02-20 | — | — | EP | disclosed |
| EP-0405682-A1 | Dental remineralization | Colgate-Palmolive Company (US) | 1991-01-02 | — | — | EP | disclosed |
| EP-0395117-A2 | Oral treatment and manufacture of an oral composition | THE PROCTER & GAMBLE COMPANY (US) | 1990-10-31 | — | — | EP | disclosed |
| EP-0345821-A1 | Oral compositions | THE PROCTER & GAMBLE COMPANY (US) | 1989-12-13 | — | — | EP | disclosed |
| EP-0319516-A2 | Oral compositions | THE PROCTER & GAMBLE COMPANY (US) | 1989-06-07 | — | — | EP | disclosed |
| EP-0297212-A2 | Oral compositions | THE PROCTER & GAMBLE COMPANY (US) | 1989-01-04 | — | — | EP | disclosed |
| EP-0297213-A2 | Oral treatment and use of an oral composition | THE PROCTER & GAMBLE COMPANY (US) | 1989-01-04 | — | — | EP | disclosed |
| EP-0297211-A2 | Oral compositions | THE PROCTER & GAMBLE COMPANY (US) | 1989-01-04 | — | — | EP | disclosed |